Literature DB >> 23973223

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3.

Zuojia Chen1, Joseph Barbi2, Shurui Bu2,3, Huang-Yu Yang2,4, Zhiyuan Li1, Yayi Gao1, Dilini Jinasena2, Juan Fu2, Fang Lin1, Chen Chen1, Jing Zhang2, Ning Yu5, Xiangpei Li5, Zhao Shan1, Jia Nie1, Zhimei Gao1, Hong Tian6, Yangyang Li1, Zhengju Yao1, Ying Zheng2, Benjamin V Park2, Ziyi Pan2, Jing Zhang2, Eric Dang2, Zhiguang Li2, Honglin Wang7, Weibo Luo8, Liwu Li6, Gregg L Semenza8, Song-Guo Zheng9, Karin Loser10, Andy Tsun1, Mark I Greene11, Drew M Pardoll2, Fan Pan2, Bin Li1.   

Abstract

Regulatory T (Treg) cells suppress inflammatory immune responses and autoimmunity caused by self-reactive T cells. The key Treg cell transcription factor Foxp3 is downregulated during inflammation to allow for the acquisition of effector T cell-like functions. Here, we demonstrate that stress signals elicited by proinflammatory cytokines and lipopolysaccharides lead to the degradation of Foxp3 through the action of the E3 ubiquitin ligase Stub1. Stub1 interacted with Foxp3 to promote its K48-linked polyubiquitination in an Hsp70-dependent manner. Knockdown of endogenous Stub1 or Hsp70 prevented Foxp3 degradation. Furthermore, the overexpression of Stub1 in Treg cells abrogated their ability to suppress inflammatory immune responses in vitro and in vivo and conferred a T-helper-1-cell-like phenotype. Our results demonstrate the critical role of the stress-activated Stub1-Hsp70 complex in promoting Treg cell inactivation, thus providing a potential therapeutic target for the intervention against autoimmune disease, infection, and cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23973223      PMCID: PMC3817295          DOI: 10.1016/j.immuni.2013.08.006

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  39 in total

1.  Stability of the regulatory T cell lineage in vivo.

Authors:  Yuri P Rubtsov; Rachel E Niec; Steven Josefowicz; Li Li; Jaime Darce; Diane Mathis; Christophe Benoist; Alexander Y Rudensky
Journal:  Science       Date:  2010-09-24       Impact factor: 47.728

Review 2.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

4.  Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress.

Authors:  Dimitrios Mougiakakos; C Christian Johansson; Regina Jitschin; Martin Böttcher; Rolf Kiessling
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

5.  Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.

Authors:  Petra Hoffmann; Tina J Boeld; Ruediger Eder; Jochen Huehn; Stefan Floess; Georg Wieczorek; Sven Olek; Wolfgang Dietmaier; Reinhard Andreesen; Matthias Edinger
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

6.  Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.

Authors:  Eric V Dang; Joseph Barbi; Huang-Yu Yang; Dilini Jinasena; Hong Yu; Ying Zheng; Zachary Bordman; Juan Fu; Young Kim; Hung-Rong Yen; Weibo Luo; Karen Zeller; Larissa Shimoda; Suzanne L Topalian; Gregg L Semenza; Chi V Dang; Drew M Pardoll; Fan Pan
Journal:  Cell       Date:  2011-08-25       Impact factor: 41.582

7.  Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease.

Authors:  Margarita Dominguez-Villar; Clare M Baecher-Allan; David A Hafler
Journal:  Nat Med       Date:  2011-05-03       Impact factor: 53.440

Review 8.  Regulatory T cells in tumor immunity.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

9.  Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha.

Authors:  Weibo Luo; Jun Zhong; Ryan Chang; Hongxia Hu; Akhilesh Pandey; Gregg L Semenza
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

Review 10.  Plasticity of CD4(+) FoxP3(+) T cells.

Authors:  Xuyu Zhou; Samantha Bailey-Bucktrout; Lukas T Jeker; Jeffrey A Bluestone
Journal:  Curr Opin Immunol       Date:  2009-06-06       Impact factor: 7.486

View more
  147 in total

1.  How regulatory T cells sense and adapt to inflammation.

Authors:  Bin Li; Song Guo Zheng
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

Review 2.  Blood-based signatures in type 1 diabetes.

Authors:  Susanne M Cabrera; Yi-Guang Chen; William A Hagopian; Martin J Hessner
Journal:  Diabetologia       Date:  2015-12-23       Impact factor: 10.122

Review 3.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

4.  SHARPINing the knowledge of TCR signal control.

Authors:  Melissa Bowman; Fan Pan; Edward W Harhaj
Journal:  Nat Immunol       Date:  2016-03       Impact factor: 25.606

Review 5.  The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases.

Authors:  Benjamin V Park; Fan Pan
Journal:  Cell Mol Immunol       Date:  2015-09       Impact factor: 11.530

6.  Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis.

Authors:  Sihua Wang; Yuan Zhang; Yan Wang; Ping Ye; Jun Li; Huabin Li; Qingqing Ding; Jiahong Xia
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

7.  β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.

Authors:  Jia Ma; Yanwei Lu; Sheng Zhang; Yan Li; Jing Huang; Zhongyuan Yin; Jinghua Ren; Kai Huang; Li Liu; Kunyu Yang; Gang Wu; Shuangbing Xu
Journal:  Cell Death Differ       Date:  2018-02-02       Impact factor: 15.828

Review 8.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

9.  Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction.

Authors:  Shok Ping Lim; Benedetta Costantini; Syed A Mian; Pilar Perez Abellan; Shreyans Gandhi; Marc Martinez Llordella; Juan Jose Lozano; Rita Antunes Dos Reis; Giovanni A M Povoleri; Thanos P Mourikis; Ander Abarrategi; Linda Ariza-McNaughton; Susanne Heck; Jonathan M Irish; Giovanna Lombardi; Judith C W Marsh; Dominique Bonnet; Shahram Kordasti; Ghulam J Mufti
Journal:  Blood       Date:  2020-08-13       Impact factor: 22.113

Review 10.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.